Hong Chang

22PUBLICATIONS
23CO-AUTHORS
Molecular targetsCellular immunologyHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 15, 2026
CD47 promotes myeloma cell growth through JAK-STAT3/MYC signalling and is targetable by ruxolitinib.

|Apr 17, 2026
Intracellular IL-23R is necessary for mitotic spindle formation and viability in AML.

|Oct 16, 2025
Uncommon Evolution From Acute Myeloid Leukaemia to JAK2-Mutated Myeloproliferative Neoplasm: Evidence of Clonal Persistence and Divergence From TET2/SRSF2-Mutated Haematopoietic Progenitors.

Mark Anthony Turingan, Ehsan Bahrami Hezaveh, Cuihong Wei

|May 13, 2025
Genetic Landscape and Risk Stratification of AML With Hyperdiploid Karyotype.

Ehsan Bahrami Hezaveh, Jiong Yan, Davidson Zhao

|Nov 17, 2024
Somatic co-alteration signatures are prognostic in high-grade TP53-mutated myeloid neoplasms.

Emily O Symes, Peng Wang, Payal Sojitra

|Sep 17, 2020
Laboratory practices for manual blood film review: Results of an IQMH patterns of practice survey.

Elaine Leung, Anna Johnston, Brian Olsen

Pageof 4

Frequent Collaborators

2 joint publications

Davidson Zhao

1 joint publications

Elaine Leung

1 joint publications

Anna Johnston

1 joint publications

Rumina Musani